Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Journal: Journal of the American Heart Association
Published: May 23, 2024
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
Journal: Journal of the American Heart Association
Published: September 27, 2021
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF.
Journal: Heart rhythm O2
Published: August 02, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF.
Journal: American heart journal
Published: November 17, 2020
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF.
Journal: Cardiology and therapy
Published: June 24, 2019
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
Journal: JAMA cardiology
Published: April 25, 2019
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.
Journal: Journal of the American Heart Association
Published: October 30, 2018
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
Journal: The New England journal of medicine
Published: August 28, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF.
Journal: European heart journal. Quality of care & clinical outcomes
Published: July 19, 2018
Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF.
Journal: American heart journal
Published: August 24, 2017
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.
Journal: Clinical cardiology
Published: August 11, 2017
Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
Journal: Journal of the American Heart Association
Published: June 16, 2017
Last Updated: 09/26/2026